chabeli: so wi those, we hear that it's really demand driven, right?rd from johnson and johnson, who's the main manufacturer of these medications, that this cold, flu, covid-19, rsveason from the fall really, really ramped up the demand for these medications. we had people who were buying them proactively and now we are seeing parents buying alternatives, generics, different forms. i think that situation is getting a little better, but it's still definitely with us as well. ali: and the antibiotic amoxicillin is also in short supply. that, of course, treats bacterial infections, not viruses. what's behind that? chabeli: what's happened with amoxicillin is, again, we're seeing a demand driven shortage. and again, we are seeing that pediatricians are switching to different antibiotics to help kids. but what that's causing is a cascade effect. and so that is really just layering and layering and layering on top of all of these otr shortages that are happening at the same time. and they're all affecting really sort of the same group of people, right? kids